A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...
A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, ...
Scientists and studies have long found that people of all ages who are regularly touched tend to be less anxious, recover ...
SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...
Verywell Health on MSN9d
Injectable Alzheimer's Drugs Could Save Patients Trips to the HospitalEisai is seeking approval for an injectable version of Leqembi while Eli Lilly is developing a new injectable drug. These ...
New research comparing different approaches to dementia care for people with Alzheimer's disease and other dementias found no ...
Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...
The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...
Verywell Health on MSN3d
Why It's Hard for Patients to Get the Newest Alzheimer's DrugsAccess to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...
New research is drawing a connection between gut health and Alzheimer’s Disease. Scientists at ASU and Banner Alzheimer’s ...
POTOMAC, MD / ACCESS Newswire / January 28, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") is proud to announce its selection as one of the top 15 finalists in the PREPARE ...
New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer's disease in older adults. The diagnostic criteria for limbic-predominant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback